Related Experiment Video
Updated: May 14, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Rechargeable vs. nonrechargeable internal pulse generators in the management of dystonia
Martin J Gillies1, Carole Joint, Beth Forrow
1Department of Neurological Surgery, Oxford University Hospitals, Oxford, UK. martin.gillies@ouh.nhs.uk
Objective:
To test if deep brain stimulation (DBS) treatment of dystonia was similar in patients before and after implantation of rechargeable internal pulse generators (IPGs).
Materials And Methods:
The Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) severity and disability scores were compared in patients before DBS insertion, 24 months after DBS insertion with a nonrechargeable IPG, and after implantation of a rechargeable IPG.
Results:
No significant differences were observed between dystonia control in patients before and after implantation of a rechargeable IPG.
Conclusions:
Rechargeable IPGs should be the IPGs of choice for dystonic patients receiving DBS as IPGs offer similar treatment efficacy to nonrechargeable IPGs with advantages in terms of costs and reductions in reimplantation frequency.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Alterations in Muscle Tone ll
Alterations in Muscle Tone lll
Depolarizing Blockers: Pharmocokinetics
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...

